European guidance for the diagnosis and management of osteoporosis in postmenopausal women

被引：332

作者：

Kanis, J. A. ^{[1
]}

Burlet, N. ^{[2
]}

Cooper, C. ^{[3
]}

Delmas, P. D. ^{[4
,5
]}

Reginster, J. -Y. ^{[6
]}

Borgstrom, F. ^{[7
]}

Rizzoli, R. ^{[8
]}

机构：

[1] Univ Sheffield, Sch Med, WHO, Collaborating Ctr Metab Bone Dis, Sheffield S10 2RX, S Yorkshire, England

[2] IOF, Nyon, Switzerland

[3] Univ Southampton, Epidemiol Res Ctr, MRC, Southampton, Hants, England

[4] Univ Lyon, Lyon, France

[5] INSERM, Res U831, F-69008 Lyon, France

[6] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspect Rheumat Dis, CHU Ctr Ville, Liege, Belgium

[7] i3 Innovus, Stockholm, Sweden

[8] Univ Hosp Geneva, Serv Bone Dis, WHO, Collaborating Ctr Osteoporosis Prevent, Geneva, Switzerland

来源：

OSTEOPOROSIS INTERNATIONAL | 2008年 / 19卷 / 04期

关键词：

bone mineral density; diagnosis of osteoporosis; fracture risk assessment; health economics; treatment of osteoporosis;

D O I：

10.1007/s00198-008-0560-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women with or at risk from osteoporosis. Introduction The European Foundation for Osteoporosis and Bone disease (subsequently the International Osteoporosis Foundation) published guidelines for the diagnosis and management of osteoporosis in 1997. This manuscript updates these in a European setting. Methods The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; monitoring of treatment; assessment of fracture risk; case finding strategies; investigation of patients; health economics of treatment. Results and conclusions A platform is provided on which specific guidelines can be developed for national use.

引用

页码：399 / 428

页数：30

共 50 条

[41] Osteoporosis in postmenopausal women
Moe, Samantha
Paige, Allison
Allan, G. Michael
CANADIAN FAMILY PHYSICIAN, 2021, 67 (05) : 346 - 346
[42] Similarities and differences between European guidelines for the management of postmenopausal osteoporosis
Cortet, Bernard
Guanabens, Nuria
Brandi, Maria Luisa
Siggelkow, Heide
ARCHIVES OF OSTEOPOROSIS, 2024, 19 (01)
[43] The clinical value of BALP on diagnosis and treatment of osteoporosis in postmenopausal women
Weiguo Li1
The Journal of Biomedical Research, 2006, (06) : 331 - 334
[44] MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
DIRENZO, GC
COATA, G
COSMI, EV
MELIS, GB
MAIETTA, L
VOLPE, A
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1994, 56 (01): : 47 - 53
[45] MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
PRIER, A
SEMAINE DES HOPITAUX, 1986, 62 (35-36): : 2850 - 2852
[46] Management of Postmenopausal Osteoporosis
Andreopoulou, Panagiota
Bockman, Richard S.
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 329 - 342
[47] Management of Postmenopausal Osteoporosis
Pinkerton, JoAnn, V
Chelmow, David
Witkop, Catherine T.
OBSTETRICS AND GYNECOLOGY, 2022, 139 (04): : 698 - 717
[48] Postmenopausal osteoporosis management
Gambacciani, M
Ciaponi, M
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2000, 12 (03) : 189 - 197
[49] THE EFFECTS OF HEALTH MANAGEMENT INTERVENTION ON POSTMENOPAUSAL OSTEOPOROSIS WOMEN TREATMENT
Lin, Hua
Chen, Xin
Zhu, Xiufen
Qian, Chen
OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S149 - S150
[50] Pharmacological Management of Osteoporosis in Postmenopausal Women: The Current State of the Art
Gatti, Davide
Fassio, Angelo
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2019, 26 (04): : E1 - E17

← 1 2 3 4 5 →